1. Associations of overweight and metabolic health with successful aging: 32-year follow-up of the Helsinki Businessmen Study
- Author
-
Arto Y. Strandberg, Veikko Salomaa, Timo E. Strandberg, Annele Urtamo, Mika Kivimäki, Mikaela B. von Bonsdorff, Satu K. Jyväkorpi, Kari Luotola, Clinicum, University of Helsinki, Helsinki University Hospital Area, HUS Heart and Lung Center, HUS Gynecology and Obstetrics, Department of Medicine, HUS Internal Medicine and Rehabilitation, and Timo Strandberg / Principal Investigator
- Subjects
Male ,0301 basic medicine ,Aging ,FITNESS ,IMPACT ,RAND-36 ,Successful aging ,Metabolically healthy overweight and obesity ,elämänlaatu ,Overweight ,Critical Care and Intensive Care Medicine ,OLD-AGE ,0302 clinical medicine ,Quality of life ,QUALITY-OF-LIFE ,aineenvaihdunta ,Finland ,RISK ,Nutrition and Dietetics ,Hazard ratio ,ylipaino ,Middle Aged ,3. Good health ,CARDIOVASCULAR-DISEASE ,OBESITY ,3143 Nutrition ,medicine.symptom ,medicine.medical_specialty ,030209 endocrinology & metabolism ,03 medical and health sciences ,Internal medicine ,medicine ,Humans ,Aged ,030109 nutrition & dietetics ,Metabolically unhealthy overweight and obesity ,business.industry ,MORTALITY ,Odds ratio ,medicine.disease ,Obesity ,Confidence interval ,BODY-MASS INDEX ,ikääntyminen ,PHYSICAL-ACTIVITY ,Nonagenarians ,business ,Body mass index ,Follow-Up Studies - Abstract
Background & aims: Prognostic significance of metabolically healthy overweight and obesity (MHO) is under debate. However the relationship between MHO and health-related quality of life (HRQoL) is less studied. We compared successful aging (longevity plus HRQoL) in men with MHO, metabolically healthy normal weight (MHN) and metabolically unhealthy overweight and obesity (MUO). Methods: In the Helsinki Businessmen Study longitudinal cohort, consisting of men born 1919 to 1934. In 1985/86, overweight (BMI >= 25 kg/m(2)) and metabolic health were determined in 1309 men (median age 60 years). HRQoL was assessed using RAND-36/SF-36 in 2000 and 2007, and all-cause mortality retrieved from registers up to 2018. The proportion of men reaching 90 years was also calculated. Results: Of the men, 469 (35.8%), 538 (41.1%), 276 (21.1%), and 26 (2.0%) were MHN, MHO, MUO and MUN, respectively. During the 32-year follow-up, 72.3% men died. With MHN as reference, adjusted hazard ratio with all-cause mortality was 1.08 (95% confidence interval [CI] 0.93 to 1.27) for MHO, and 1.18 (95% CI 0.95 to 1.47) for MUO. During follow-up, 273 men reached 90 years. With MHN as reference, adjusted odds ratio for MHO was 0.82 (95% CI 0.59 to 1.14) and 0.62 (95% CI 0.41 to 0.95) for MUO. Men in MHN group scored generally highest in RAND-36 HRQoL subscales in 2000 and 2007, of those significantly better in Physical functioning, Role physical, Role emotional, Bodily Pain, and General health sub-scales compared to MHO group in 2000. Conclusions: As compared to MHN, MHO in late midlife does not increase mortality, but impairs odds for successful aging. (C) 2019 Elsevier Ltd and European Society for Clinical Nutrition and Metabolism. All rights reserved.
- Published
- 2020
- Full Text
- View/download PDF